Sepsis to Septic Shock by Whitlow, Seth
Otterbein University 
Digital Commons @ Otterbein 
Nursing Student Class Projects (Formerly MSN) Student Research & Creative Work 
Summer 7-27-2017 
Sepsis to Septic Shock 
Seth Whitlow 
seth_whitlow@hotmail.com 
Follow this and additional works at: https://digitalcommons.otterbein.edu/stu_msn 
 Part of the Critical Care Nursing Commons 
Recommended Citation 
Whitlow, Seth, "Sepsis to Septic Shock" (2017). Nursing Student Class Projects (Formerly MSN). 259. 
https://digitalcommons.otterbein.edu/stu_msn/259 
This Project is brought to you for free and open access by the Student Research & Creative Work at Digital 
Commons @ Otterbein. It has been accepted for inclusion in Nursing Student Class Projects (Formerly MSN) by an 
authorized administrator of Digital Commons @ Otterbein. For more information, please contact 
digitalcommons07@otterbein.edu. 
Sepsis	  to	  Septic	  Shock
Seth	  Whitlow	  RN,	  BSN
References
NURS	  5330	  
Signs / SymptomsBackground Pathophysiology
Conclusions
Clinical Significance
Implications to Nursing Care
Risk Factors
Sepsis
• Specific to region related to primary offense (ex:  cough r/t 
pneumonia, pain r/t non-healing wound, abdominal pain r/t 
pancreatitis)
• Hypotension (SBP < 90mmHg, MAP < 70mmHg)
• Temperature > 38.3C or < 36C
• Heart Rate > 90 beats/minute
• Tachypnea – RR > 20breaths/minute
Source:  (Rhodes et al., 2017), (Singer et al., 2016)
Laboratory Markers
• Leukocytosis (WBC>12K) or Leukocytopenia (WBC < 4K)
• Hyperglycemia (serum glucose > 14mg/dl)
• Arterial hypoxemia (PaO2/FiO2 < 300)
• Oliguria (UOP < 0.5ml/kg/hr)
• Thrombocytopenia (platelet < 100K)
• Hyperlactatemia (lactate >2mmol/L)
• Coagulation dysfunction (INR>1.5, aPTT>60 seconds)
Source: (Rhodes et al., 2017), (Laszlo et al., 2015)
Septic Shock
Clinical presentation includes previous sign/symptoms but the 
patient requires vasopressor support to maintain mean arterial 
pressure > 65mmHg and hyperlactitemia > 2mmol/L despite 
adequate fluid resuscitation.  Septic shock represent an advanced 
diagnosis where circulatory, cellular, and metabolic abnormalities 
reflect increased patient mortality.
Source: (Laszlo et al., 2015), (Gotts & Matthay, 2016)
Sepsis	  has	  long	  been	  part	  of	  medicine	  and	  
conceptualized	  using	  multiple	  definitions	  
and	  criteria.	  	  Without	  consistent	  and	  
reproducible	  criteria	  the	  extensive	  
pathophysiology	  associated	  with	  sepsis	  is	  
difficult	  to	  diagnose	  and	  treat.	  	  The	  CDC	  
reports	  approximately	  1	  million	  patients	  
are	  diagnosed	  with	  sepsis	  each	  year	  
(Sepsis,	  2016).	  	  Treatment	  guidelines	  are	  
ambiguous	  and	  patients	  incur	  a	  prolonged	  
hospital	  stay	  while	  receiving	  complex	  
therapy.	  	  Patients	  diagnosed	  with	  sepsis	  
reflect	  an	  in-­‐hospital	  mortality	  risk	  of	  10%	  
and	  those	  who	  develop	  septic	  shock	  
increase	  their	  mortality	  risk	  greater	  than	  
40%	  (Singer,	  et	  al.,	  2016).	  	  In	  2016,	  a	  task	  
force	  consisting	  of	  international	  healthcare	  
clinicians	  who	  lead	  the	  world	  in	  sepsis	  
pathophysiology,	  clinical	  trials	  and	  sepsis	  
epidemiology	  convened	  a	  consensus	  to	  
develop	  updated	  definitions	  and	  criteria	  
related	  to	  sepsis.	  	  Singer	  et	  al.	  (2016)	  
proposed	  sepsis	  is	  a	  “life-­‐threatening	  organ	  
dysfunction	  caused	  by	  dysregulated	  host	  
response	  to	  infection”.	  	  Furthermore,	  septic	  
shock	  is	  the	  bodies	  deterioration	  affecting	  
circulation	  and	  cellular	  metabolic	  
homeostasis	  thus	  increasing	  mortality	  
(Singer,	  et	  al.,	  2016).	  	  Outside	  the	  critical	  
care	  arena	  sepsis	  is	  often	  misdiagnosed	  
thus	  increasing	  healthcare	  costs	  thru	  delay	  
in	  treatment	  all	  while	  increasing	  patient	  
mortality	  (Mouncey et	  al.,	  2015). Sepsis is a diagnosis that can affect anyone susceptible to an 
infecting organism.  Sepsis and septic shock are the host 
organisms reaction to infection and the inability of an 
adequate immune response.  Risk factors associated with 
sepsis and septic shock include:
• ICU admission
• Bacteremia
• Age > 65 yo
• African Americans > risk of developing sepsis
• Male > female
• Immunocompromised
• Comordities (ie Diabetes, Cancer)
• Previous hospitalization
• Community acquired pneumonia
Source:  (Prescott et al., 2015), (Sepsis, 2016), 
Modifiable Risk Factors
• Alcohol consumption
• Cigarette smoking
• Vitamin B12 deficiency 
• Vaccination 
Source:  (Gotts & Matthay, 2016)
Sepsis is a “life-threatening organ dysfunction caused by dysregulated host 
response to infection (Singer et al., 2016).  The normal host reaction to pathogens 
involves adequate immune response including innate and adaptive immunity.  
Sepsis involves the pro-inflammatory mediators transitions beyond the local site to 
wreak systemic influences which become generalized (Laszlo et al., 2015).  Basic 
sepsis pathophysiology involves increased cardiac output when systemic vascular 
resistance is decreased given biventricular deterioration.  General abnormalities 
associated with sepsis include excessive alterations in endothelium along with 
microcirculatory impairment (Gotts & Matthay, 2016). 
Inflammation Pathway Discord
• Macrophage, monocytes, granulocytes, natural killer cells – detect pathogen 
associated molecular patterns (PAMP) and damage associated molecular 
patterns (DAMP)
• PAMP + DAMP activate innate immune response after binding to Toll-like 
receptors C-type lectin receptors, resulting in secretion of pro-inflammatory 
mediators TNF-a, IL1, and IL6.
• Inflammatory cytokines initiate complement cascades (C5a) which promotes 
reactive oxygen species (ROS) and nitric oxide to impair cellular proteins and 
function, DNA, and mitochondria ATP output
• Results:  increased endothelium permeability, systemic immunothrombosis with 
microvascular impaired function (DIC)
Metabolic Dysfunction
• Decreased ATP production at cellular level leads to hypoxia
• Results:  catabolism with significant reduction in muscle mass, acute kidney 
injury, myocardial depression, hepatic dysfunction, endothelial and epithelial 
permeability causing acute lung injury
Organ / Tissue Impairment
• Alteration to endothelium permeability:  Lungs – protein rich edema fills 
interstitial tissue, leads V/Q mismatch, arterial hypoxemia, ARDS
• Liver:  hepatocyte dysfunction; inability to clear bilirubin
• Kidney:  cytokine and immune mediated microvascular dysfunction
• Nervous system: encephalopathy related to compromised blood brain barrier 
endothelium and pathogen infection
• Spleen:  depeleted CD4, CD8 Tcells affect long term host immune response
Source (Gotts & Matthay, 2016)
In 2002, the Surviving Sepsis Campaign started a quality improvement 
initiative to improve knowledge related to sepsis, improve diagnosis, 
and develop guidelines of care.  Amongst the various strategies is the 
Surviving Sepsis Campaign Bundles (SSCB).  These guidelines focus 
care to satisfy elements that, when done collectively, improve patient 
outcomes.  Nurses represent a vital role in the healthcare continuum for 
recognizing early signs and symptoms related to sepsis.  Many 
healthcare institutions have customized the SSCB which allows the ICU 
nurse to initiate established protocol based on agreed upon criteria 
(Surviving Sepsis, 2015).  One approved diagnostic tool is use of the 
quick SOFA (sequential organ failure assessment) score.  A positve
screen reflects 2 of 3 criteria including:  respiratory rate > 22 bpm, 
Glasgow coma scale < 15, and/or SBP < 100 mmHg (Gotts & Matthay, 
2016).  
End Stage Organ Dysfunction
Source: (Iskander et al., 2013)
Sepsis has proven to be an elusive diagnosis where one size does not 
fit all.  The inability to stage the disease given the multitude of disease 
progression continues to cause controversy in the management of 
sepsis. The Surviving Sepsis Campaign was convened to establish 
unifying criteria on definition, treatment and prevention protocols 
proven to combat sepsis (Howell & Davis, 2017).  Accepted 
guidelines call for rapid administration of broad-spectrum antibiotics 
within 1 hour of suspected sepsis event.  Each hour in the delay of 
antibiotic therapy is associated with a 12% reduction in surviving a 
septic diagnosis(Gotts & Matthay, 2016).  After antibiotic therapy has 
been initiated, guidelines call for pan-culture to identify the infective 
microorganism.  Crystalloid fluid resuscitation is used to maintain a 
MAP > 65mmHg (Howell & Davis, 2017).  If hypotension persists, 
first line drug therapy should be norepinephrine.  Mechanical 
ventilation may be indicated for sustained hypoxemia with PaO2 < 75 
(Howell & Davis, 2017).  In general, the role of the healthcare 
practitioner is to optimize the host defense and response to an 
infecting organism (Gotts & Matthay, 2016).
Patients suffering from invading microrganism develop sepsis 
that often deteriorates to septic shock.  It is s a common 
disease process with a vast and complex progression through 
multiple systems in the body.  The dynamic nature of sepsis 
leads to challenges in the management  of sepsis.  The 
overwhelming and sometime contrasting nature of proven 
therapies leads to it being a deadly and expensive diagnosis 
seen throughout healthcare.  Since national consensus and 
guidelines have been implemented there has been 
improvements in outcomes, while the rate of sepsis has also 
increased.  This is due to vigilance in disease identification, 
rapid delivery of antibiotic therapy, and supportive treatments 
to subsequent organ failure.  Critical care nurses play a vital 
role in early detection and initiation of sepsis protocols.    
Critical to improving patient mortality requires the bedside 
nurse to understand sepsis pathophysiology, signs and 
symptoms, and anticipate disease progression while 
monitoring the patient clinical response to treatment.
Infecting Microorganisms
Pathogens associated with sepsis are 
predominantly derived from the blood 
stream, lungs, kidneys and GI tract.  
• Gram Positive:  47%
• Gram Negative:  62%
• Fungal:  19%
Source: (Gotts & Matthay, 2016)
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